Oral Erectile Dysfunction Therapeutic Market

Erectile dysfunction (ED) is the type of sexual dysfunction when a man cannot maintain a firm erection of the penis or coitus. Oral Erectile Dysfunction Therapeutic Market contains market size and forecasts of Oral Erectile Dysfunction Therapeutic in global, including the following market information: Global Oral Erectile Dysfunction Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions) Global Oral Erectile Dysfunction Therapeutic Market Sales, 2017-2022, 2023-2028, (K Units) Global top five Oral Erectile Dysfunction Therapeutic companies in 2021 (%) The global Oral Erectile Dysfunction Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Protein Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Oral Erectile Dysfunction Therapeutic include Eli Lilly, Pfizer, Bayer, Teva Pharma, S.K. Chemicals, Seoul Pharma and CSBIO., etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Erectile Dysfunction Therapeutic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Oral Erectile Dysfunction Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units) Global Oral Erectile Dysfunction Therapeutic Market Segment Percentages, by Type, 2021 (%) Protein Hormones Other Global Oral Erectile Dysfunction Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units) Global Oral Erectile Dysfunction Therapeutic Market Segment Percentages, by Application, 2021 (%) Age <20 Age 20-30 Age 31-40 Age 41-50 Age >50 Global Oral Erectile Dysfunction Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units) Global Oral Erectile Dysfunction Therapeutic Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Oral Erectile Dysfunction Therapeutic revenues in global market, 2017-2022 (Estimated), ($ millions) Key companies Oral Erectile Dysfunction Therapeutic revenues share in global market, 2021 (%) Key companies Oral Erectile Dysfunction Therapeutic sales in global market, 2017-2022 (Estimated), (K Units) Key companies Oral Erectile Dysfunction Therapeutic sales share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Eli Lilly Pfizer Bayer Teva Pharma S.K. Chemicals Seoul Pharma CSBIO.